Evaluation of Patients With Covid-19 Diagnosis for Chronic Diseases
Aim: Covid-19 is one of the most important pandemics in the world history. Chronic diseases, which are risk factors that increase the case fatality rates, have been the leading cause of death all over the world. In this study, it was aimed to detect coexisting diseases in patients hospitalized with the diagnosis of Covid-19.
Material and Method: It was carried out with the data of 229 inpatients in an intensive care unit between 01.06.2020 - 30.06.2020. Among the inclusion criteria of the study; it is necessary to have a diagnosis confirmed by PCR test, to be hospitalized in the relevant intensive care unit on the date of the study and to have data accessible through the hospital automation system. According to literature; chronic diseases of the patients and their effects on the covid-19 process were evaluated. Statistical analyzes were performed using the Statistical Package for Social Sciences (SPSS) version 24.0 (IBM Corp .; Armonk, NY, USA).
Results: It was seen that the average age of the patients were 61.4±15.9 years old. While the average symptom duration was 8.2±5.3 days; total hospitalization period was 13.1±5.9 days. The length of stay of 75 patients who were sent to intensive care unit was determined as 10.1±7.1. The most common chronic disease among patients was hypertension with 47.2%. This was followed by diabetes mellitus (32.8%) and heart disease (27.5%), respectively. In the presented study, cough (59.4%), fever (58.5%) and shortness of breath (45.9%) were found to be the most common symptoms. Leukopenia, impairments in liver and muscle enzymes, abnormal C-reactive protein, ferritin and d-dimer levels were the important laboratory findings.
Conclusion: Particular attention should be paid to the elderly Covid-19 patients with chronic diseases, especially DM, HT and cancer.
Posted 30 Dec, 2020
Received 10 Jan, 2021
On 10 Jan, 2021
Received 09 Jan, 2021
Received 06 Jan, 2021
Received 02 Jan, 2021
On 26 Dec, 2020
On 25 Dec, 2020
On 24 Dec, 2020
Invitations sent on 23 Dec, 2020
On 23 Dec, 2020
On 21 Dec, 2020
On 21 Dec, 2020
On 21 Dec, 2020
On 15 Dec, 2020
Evaluation of Patients With Covid-19 Diagnosis for Chronic Diseases
Posted 30 Dec, 2020
Received 10 Jan, 2021
On 10 Jan, 2021
Received 09 Jan, 2021
Received 06 Jan, 2021
Received 02 Jan, 2021
On 26 Dec, 2020
On 25 Dec, 2020
On 24 Dec, 2020
Invitations sent on 23 Dec, 2020
On 23 Dec, 2020
On 21 Dec, 2020
On 21 Dec, 2020
On 21 Dec, 2020
On 15 Dec, 2020
Aim: Covid-19 is one of the most important pandemics in the world history. Chronic diseases, which are risk factors that increase the case fatality rates, have been the leading cause of death all over the world. In this study, it was aimed to detect coexisting diseases in patients hospitalized with the diagnosis of Covid-19.
Material and Method: It was carried out with the data of 229 inpatients in an intensive care unit between 01.06.2020 - 30.06.2020. Among the inclusion criteria of the study; it is necessary to have a diagnosis confirmed by PCR test, to be hospitalized in the relevant intensive care unit on the date of the study and to have data accessible through the hospital automation system. According to literature; chronic diseases of the patients and their effects on the covid-19 process were evaluated. Statistical analyzes were performed using the Statistical Package for Social Sciences (SPSS) version 24.0 (IBM Corp .; Armonk, NY, USA).
Results: It was seen that the average age of the patients were 61.4±15.9 years old. While the average symptom duration was 8.2±5.3 days; total hospitalization period was 13.1±5.9 days. The length of stay of 75 patients who were sent to intensive care unit was determined as 10.1±7.1. The most common chronic disease among patients was hypertension with 47.2%. This was followed by diabetes mellitus (32.8%) and heart disease (27.5%), respectively. In the presented study, cough (59.4%), fever (58.5%) and shortness of breath (45.9%) were found to be the most common symptoms. Leukopenia, impairments in liver and muscle enzymes, abnormal C-reactive protein, ferritin and d-dimer levels were the important laboratory findings.
Conclusion: Particular attention should be paid to the elderly Covid-19 patients with chronic diseases, especially DM, HT and cancer.